Skip to main content
Future Journal of Pharmaceutical Sciences

Table 7 Assay of tablets

From: Stability-indicating method development and validation for the concurrent determination of darunavir, cobicistat, emtricitabine and tenofovir alafenamide by UPLC in bulk and tablet dosage forms

Drug

Label claim (mg/tab)

Amount found (mg)

% assay

TAF

10

9.97

99.66

COBI

150

150

100.00

FTC

200

200.44

100.22

DRV

800

802.4

100.30

  1. TAF tenofovir alafenamide, COBI cobicistat, FTC emtricitabine, DRV darunavir, % percentage, mg/tab milligram/tablet
Back to article page